To investigate the interactions between CD4+ and CD8+ T cells, we first assessed the changes of CD4+ and CD8+ T cells in a B16F10 tumor model early after CTT (day 7), during the priming phase of CTT-induced Th1-dominant differentiation. The gene discussed is CD8A; the disease is neoplasm.